AURA - Aura Biosciences, Inc.

5.36
0.130   2.425%

Share volume: 396,162
Last Updated: 04-09-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.03%

PREVIOUS CLOSE
CHG
CHG%
$5.23
0.13
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
21%
Profitability 0%
Dept financing 4%
Liquidity 50%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-2.90%
1 Month
-25.66%
3 Months
-28.53%
6 Months
-28.53%
1 Year
-28.53%
2 Year
-28.53%
Key data
Stock price
$5.36
P/E Ratio 
0.00
DAY RANGE
$4.90 - $5.72
EPS 
-$0.52
52 WEEK RANGE
$4.90 - $7.73
52 WEEK CHANGE
-$28.53
MARKET CAP 
410.601 M
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-08-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$409,681
AVERAGE 30 VOLUME 
$447,744
Company detail
CEO: Elisabet de los Pinos
Region: US
Website: aurabiosciences.com
Employees: 50
IPO year: 2021
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

Aura Biosciences, Inc. develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.

Recent news
loading